Schizophrenia Research
Volume 112, Issue 1 , Pages 54-64, July 2009

Subcortical oligodendrocyte- and astrocyte-associated gene expression in subjects with schizophrenia, major depression and bipolar disorder

  • Kevin Barley

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
  • ,
  • Stella Dracheva

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
  • ,
  • William Byne

      Affiliations

    • J.J. Peters Department of Veterans Affairs Medical Center, 130 West Kingsbridge Ave., Bronx, New York, 10468, United States
    • Department of Psychiatry, Mount Sinai School of Medicine, One Gustave Levy Place, New York, NY 10029, United States
    • Corresponding Author InformationCorresponding author. Research Bldg. Room 2F39, JJ Peters VA Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, United States.

Received 19 February 2009; received in revised form 7 April 2009; accepted 9 April 2009. published online 18 May 2009.

Abstract 

Deficits in the expression of oligodendrocyte and myelin genes have been described in numerous cortical regions in schizophrenia and affective disorders; however, relatively little attention has been paid to subcortical structures. Here we employed quantitative real time PCR to examine the mRNA expression of 17 genes that are expressed by oligodendrocyte precursors (OLPs) and their derivatives, including astrocytes. Four subcortical regions were examined (the anteroventral (AV) and mediodorsal thalamic nuclei (MDN), internal capsule (IC) and putamen (Put)) in postmortem material from subjects (age 25–68 at time of death) with no known psychiatric history (NCs) as well as in subjects with schizophrenia (SZ), major depressive disorder (MDD), and bipolar disorder (BPD). In all regions examined, genes expressed after the terminal differentiation of oligodendrocytes tended to have lower levels of mRNA expression in subjects with SZ compared to NCs. These differences were statistically significant across regions for four genes (CNP, GALC, MAG and MOG) and approached significance for TF. No genes were under expressed in MDD. Only TF was under expressed in BPD and only in the IC. In contrast, two astrocyte-associated genes (GFAP and ALDH1L1) had higher mean expression levels across regions in all psychiatric groups relative to NCs. These differences reached statistical significance for SZ and MDD relative to NCs. There were no age by diagnosis interactions. The majority of age regressions had negative slopes for the expression of oligodendrocyte-associated genes. GFAP but not ALDH1L1 expression was significantly and positively correlated with age in the MDN, AV and Put. Across subject groups the expression of both astrocyte genes was highly correlated with cumulative neuroleptic exposure in all regions except the Put. Significant positive correlations were also observed in some regions between cumulative neuroleptic exposure and the expression of genes associated with mature oligodendrocytes as well as with bipotential OLPs. Multiple negative correlations were observed between the mRNA expression of astrocyte genes and genes expressed by terminally differentiated oligodendrocytes. These data are discussed in the context of myelin turnover and potential effects of psychiatric illness as well as medications on the developmental fate of OLPs.

Keywords: Oligodendrocyte, Myelin, Schizophrenia, Bipolar disorder, Major depression, Thalamus, Mediodorsal nucleus, Anterior nucleus, Internal capsule, Putamen

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0920-9964(09)00176-5

doi:10.1016/j.schres.2009.04.019

Schizophrenia Research
Volume 112, Issue 1 , Pages 54-64, July 2009